Daily ideas

TE Connectivity posted record Q3 FY2026 sales of $5.16 billion, up 14%, with orders up 27%; Q4 results test whether AI orders become revenue as metal costs rise.

Teradyne's Q2 2026 revenue doubled to $1.33 billion at a 33.7% non-GAAP operating margin; Q3 tests how far SoC test sales fall and whether memory fills the gap.

Genuine Parts grew Q2 sales 6.0% to $6.54 billion as adjusted EBITDA margin slipped to 8.7%; Q3 tests whether pricing outruns cost inflation and NAPA holds 2% comps.

Equifax grew Q2 2026 revenue 11% to $1.70B, but only about 7% excluding FICO royalties; Q3 tests whether government verification stops falling and EWS regains 8% growth.

Regeneron's Q2 2026 revenue rose 17% to $4.29 billion, half from Sanofi's Dupixent profit share; Q3 tests whether a $253 million repaid deduction lifts operating income.

Aon's Q2 2026 revenue rose 2% to $4.246 billion on 5% organic growth and a 28.9% adjusted margin; Q3 tests whether free cash flow can catch up before the $17 billion USI deal closes.

Vertex grew Q2 2026 revenue 12% to $3.33B as CF rose 10.6% and royalties fell to 8.44%; Q3 tests whether the ALYFTREK switch keeps CF growth above 5%.

Quest Diagnostics grew Q2 2026 revenue 10.2% to $3.04 billion with core volume up 4.1% ex-partnerships; Q3 tests whether that holds as partner margin dilution narrows.

Motorola Solutions' Q2 2026 sales rose 13% to $3.13 billion with a record $15.6 billion backlog; Q3 tests whether organic LMR shipments can carry the guided Q4 ramp.

Boston Scientific grew Q2 2026 sales 7.5% to $5.44 billion before an August cyberattack halted shipping; Q3 results show how much lost revenue returns in Q4.

Enterprise Products earned $0.84 a unit in Q2 2026, up 28%, with record $2.31B distributable cash flow; Q3 tests how much Middle East spread gains fade as capex rises.

Verisign's Q2 2026 revenue rose 6.0% to $434.6 million as its .com/.net base grew 5.1%; Q3 tests whether record new registrations renew and carry revenue to guidance.

McDonald's Q2 2026 U.S. comparable sales rose only 0.8% on higher check while traffic fell; Q3 results test whether restored digital offers and the under-$3 menu stop the decline.

ONEOK posted Q2 2026 adjusted EBITDA of $2.12 billion, up 7%, on record NGL volumes; the Q3 question is whether volume growth turns back into per-barrel NGL profit.

Novo Nordisk's Q2 2026 sales rose 7% at CER to DKK 78.5 billion as gross margin fell to 78.2%; Q3 tests whether Wegovy pill uptake can offset US price cuts and patent expiry.

Dover grew Q2 2026 orders 16% to $2.33 billion against $2.19 billion of revenue; Q3 tests whether refrigeration output lets that backlog become sales and cash.

KeyCorp's Q2 2026 net interest margin rose just 2 bps to 2.89% on $1.258B of net interest income; Q3 results test whether asset repricing can outrun rising deposit costs.

Eaton's Q2 2026 sales rose 21% to $8.53 billion as Electrical Americas margins fell to 27.5%; Q3 tests whether price hikes lift that margin above 30% while backlog keeps building.

PG&E's first-half 2026 core EPS rose about 30% to $0.83 with debt at $64.2 billion; Q3 tests whether investment and cost savings alone hold the $1.64-$1.66 guidance.